Retrospective Analysis on the Gallstone Disease after Gastrectomy for Gastric Cancer

Table 3

Surgical treatment for gallstone disease after gastrectomy.

	Open cholecystectomy; ( = 30)	Laparoscopic cholecystectomy; ( = 29)	value
Age (year)	62.3 ± 2.4	55.9 ± 2.2	0.048
Gender
Male	21 (70)	12 (44.8)	0.077
Female	9 (30)	16 (55.2)
BMI (Kg/m^2)	22.6 ± 3.9	23.8 ± 3.0	0.204
Interval between gastrectomy and detection of stones (month)	49.5 ± 6.9	50.5 ± 7.8	0.918
Type of gastrectomy
Total gastrectomy	14 (46.7)	14 (48.3)	0.612
Subtotal gastrectomy	16 (53.3)	15 (51.7)
Reconstruction
Billroth I	4 (13.3)	5 (17.3)	0.417
Billroth II	11 (36.7)	7 (24.1)
Roux-en-Y	15 (50)	17 (58.6)
Indication of surgery
Silent stone	1 (3.3)	11 (37.9)	0.001
Cholecystitis	12 (40)	14 (48.3)
CBD stone or cholangitis	17 (56.7)	4 (13.8)
Interval between detection of stones and cholecystectomy (month)	11.7 ± 5.5	11.8 ± 3.2	0.936
Operation
Cholecystectomy	9 (30)	25 (86.2)	<0.001
Cholecystectomy and choledochotomy	21 (70)	4 (13.8)
Preoperative management
PTBD before cholecystectomy	1 (3.3)	1 (3.4)	0.981
PTGBD before cholecystectomy	2 (6.7)	0 (0)	0.157
ERCP before cholecystectomy	6 (20)	2 (6.9)	0.142
Operation time (min)	143 ± 8.8	82.7 ± 7.1	<0.001
EBL (mL)	218.5 ± 26.5	140.2 ± 30.7	0.059
Hospital stay (day)	10 ± 0.6	3.9 ± 0.4	<0.001
Complications	9 (30)	0 (0)	0.003
Postoperative bile leak	1 (3.3)	0 (0)
Wound infection	6 (20)	0 (0)
Pulmonary	2 (6.7)	0 (0)

PTBD = percutaneous transhepatic biliary drainage, PTGBD = percutaneous transhepatic gallbladder drainage, and ERCP = endoscopic retrograde cholangiopancreatography.